FIC: Drug Price Transparency Bill Advances To Last House Committee
By: Katrina Callaway, FIC General Counsel The House Innovation Subcommittee passed HB 589 dealing with drug price transparency on February 22, 2017. The bill was not amended. There were no questions or debate on the bill in committee. The bill expands the current law that requires the Agency for Health Care Administration (AHCA) to collect…